Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer - a Multicenter Prospective Observational Study

NCT05356039 is registered in ClinicalTrials.gov with Umeå University as lead sponsor.

NCT NCT05356039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05356039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer - a Multicenter Prospective Observational Study
Lead sponsor
Umeå University
Phase
Observational
Overall status
Recruiting
Start date
April 19, 2022
Completion date
May 31, 2028
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

borderline resectable pancreatic adenocarcinoma, chemotherapy effect, locally advanced pancreatic adenocarcinoma, pancreas adenocarcinoma, pancreas cancer, pancreas disease, pancreas neoplasm, quality of life, surgery